These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1296545)

  • 1. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of trials on regression of atheromatous lesions with hypolipemic drugs].
    Coste P; Durrieu C; Besse P
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():189-94. PubMed ID: 1285702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of atherosclerosis.
    Arntzenius AC
    Horm Metab Res Suppl; 1988; 19():19-22. PubMed ID: 3069690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
    Marchioli R; Prieto JC; Tognoni G
    Clin Trials Metaanal; 1994 Oct; 29(2-3):139-76. PubMed ID: 10150224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regression of coronary atherosclerosis: possible--and clinically relevant?].
    Niederhauser HU
    Schweiz Rundsch Med Prax; 1991 Sep; 80(39):1019-23. PubMed ID: 1925225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is regression of coronary sclerosis possible?].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1348-53. PubMed ID: 8272700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodological problems of prevention/regression trials of atherosclerosis].
    Sassano P; Benghozi R
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():139-41. PubMed ID: 1285694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic lesions in humans--plaque stabilization and regression.
    Kritz H; Sinzinger H
    Wien Klin Wochenschr; 1995; 107(18):555-66. PubMed ID: 7483643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of calcium antagonists and atherosclerosis.
    Keogh AM; Schroeder JS
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S28-35. PubMed ID: 1707112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
    Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
    Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limits of lipid-lowering therapy: the benefits of amlodipine as an anti-atherosclerotic agent.
    Kramsch DM; Sharma RC
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S3-9. PubMed ID: 7783112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression and regression of the atherosclerotic plaque.
    de Feyter PJ; Vos J; Deckers JW
    Eur Heart J; 1995 Aug; 16 Suppl I():26-30. PubMed ID: 8829954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The link between cholesterol and atherosclerosis: intervention trials].
    Milon H; Desjoyaux E; Pierrard B; Lagable M; Gayet C
    Rev Prat; 1989 Apr; 39(12):1040-4. PubMed ID: 2662362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid lowering and coronary risk.
    Gotto AM
    Isr J Med Sci; 1996 Jun; 32(6):355-9. PubMed ID: 8682640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.